Previous studies demonstrated that the CN-high molecular subtype of endometrial carcinoma was characterized by the TP53 mutation and frequently accompanied by many gene copy-number alterations, including the amplifying of essential oncogenes such as CCNE1 and c-MYC (Leskela et al., 2019). This evidence concerns the gene TP53 and endometrial carcinoma.